脚注
该手稿最近被接受在European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of theERJ在线的。请打开或下载PDF以查看本文。
Conflict of interest: Dr. Lindner has nothing to disclose.
Conflict of interest: Dr. Masoli reports grants from GlakoSmithKline, personal fees from Astra Zeneca, personal fees from Novartis, during the conduct of the study.
Conflict of interest: Mr. Lanario reports grants from GSK, during the conduct of the study; personal fees from Novartis, outside the submitted work.
利益冲突:Hyland博士在研究期间报告了GSK的赠款;在提交的工作之外,葛兰素史克的个人费用。
利益冲突:Menzies-Gow博士报告了Astra Zeneca的赠款和个人费用,Novartis的个人费用,Teva的个人费用和非财务支持,Glaxo Smithkline的个人费用,Sanofi的个人费用,Roche的个人费用,个人费用,个人费用,个人费用,个人费用,个人费用,个人费用在提交工作之外的Vectura的费用。
Conflict of interest: Dr. Mansur reports grants, personal fees, non-financial support and other from NAPP, Cheisi, Astrazeneca, GSK, Sanofi, Teva, GSK, , outside the submitted work.
利益冲突:Allen博士报告了Astra Zenaca的个人费用,GSK的个人费用,Teva的个人费用和非财务支持,在提交的工作之外。
利益冲突:多德博士没有什么可披露的。
Conflict of interest: Dr. Hayes has nothing to disclose.
Conflict of interest: Dr. Valderas has nothing to disclose.
利益冲突:莎拉·兰姆(Sarah E Lamb)在卫生技术评估(HTA)额外的容量资金委员会,HTA终止护理和附加研究委员会,HTA优先级小组委员会和HTA创伤委员会中。
利益冲突:琼斯博士在研究期间报告了葛兰素·史密斯·克莱恩(Glaxo Smith Kline)的赠款;Boehringer Ingelheim的赠款,个人费用和非财务支持,个人费用和非财务支持,赠款,个人费用和非财务支持,来自Glaxo Smith Kline,个人费用,个人费用和非财务支持,诺华,个人费用,个人费用,个人费用以及在提交工作之外的Nutricia,Null的非财务支持。
This is a PDF-only article. Please click on the PDF link above to read it.
- 已收到December 17, 2020.
- AcceptedFebruary 8, 2021.
- 复制right ©The authors 2021. For reproduction rights and permissions contactpermissions{at}ersnet.org